InvestSMART

Recce Pharmaceuticals Ltd (ASX:RCE)

ALERT: Price-sensitive ASX Announcement for RCE
Current share price for RCE : $0.370 -0.09 (-19.57%)+
Announcement
Release
24 Jun 2026 10:08AM
Price at Release
$0.460
Full Release
download
Summary
Recce Pharmaceuticals Ltd, listed on the ASX as RCE, has requested a trading halt on its securities effective from 24 June 2026. This halt is pending the release of an announcement related to a proposed equity capital raise. The halt will be in place until the earlier of the start of normal trading on 26 June 2026 or the release of the announcement. The company has indicated that there is no reason the trading halt should not be granted and has provided contact information for further inquiries.
Key Points
  • Recce Pharmaceuticals Ltd requested a trading halt.
  • Trading halt requested due to a proposed equity capital raise.
  • The trading halt effective immediately from 24 June 2026.
  • Trading halt until commencement of normal trading on 26 June 2026 or announcement release.
  • Company notifies no reason against the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.